Article Citations

(Scroll Down for More)

Clinical Trials

Core Facilities Lab Protocols Policies

Publications Policy

Publications TrialShare Strategic Plans

Atopic Dermatitis Dupilumab and anti-OX40 Treatment for Sustained Efficacy

Principal Investigator

James Krueger | The Rockefeller University | New York, NY

Locations

Study Code

ITN082AD

Study Status

Withdrawn

Abstract

Qualification

[Clinicaltrials.gov][Study Website]

Articles

Download Citations